X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Orchid Chemicals Fact Sheet, Orchid Chemicals Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Chemicals Fact Sheet   (ORCHID)

Here is the latest financial fact sheet of Orchid Chemicals. For more details, see the Orchid Chemicals quarterly results and Orchid Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.

ORCHID PHARMA LTD Price History

Price Rs 28.5
Mkt Cap Rs m 2,430
Vol '000 124.6
P/E X -0.9
P/CF X -0.8
EPS (TTM) Rs -32.1
% ch % 3.3
No. of shares m 85.26
% ch week % 2.7
% ch 1-mth % 2.9
% ch 12-mth % -29.5
52 week H/L Rs 45.9/23.7
(As on Jul 24, 2017 01:57:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ORCHID PHARMA LTD Financials

No. of Mths
Year Ending
12
Mar-09
*
12
Mar-10
*
12
Mar-11
*
12
Mar-12
*
18
Sep-13
*
5-Yr Chart
Click to enlarge
ORCHID PHARMA LTD EQUITY SHARE DATA
High Rs330239344325194 
Low Rs577512811235 
Sales per share (Unadj.) Rs184.1190.7253.0266.0276.5 
Earnings per share (Unadj.) Rs-7.048.222.213.8-79.2 
Diluted earnings per shareRs-5.739.818.311.4-65.5 
Cash flow per share (Unadj.) Rs12.170.241.135.7-43.5 
Dividends per share (Unadj.) Rs1.0010.003.003.000 
Adj. dividends per shareRs0.838.262.482.480.00 
Dividend yield (eoy) %0.56.41.31.40 
Book value per share (Unadj.) Rs90.0133.1151.8160.753.9 
Adj. book value per shareRs74.3110.0125.4132.844.6 
Shares outstanding (eoy) m70.4470.4470.4470.4470.45 
Bonus/Rights/Conversions  WC---ESOP 
Price / Sales ratio x1.10.80.90.80.4 
Avg P/E ratio x-27.83.310.615.8-1.4 
P/CF ratio (eoy) x16.02.25.76.1-2.6 
Price / Book Value ratio x2.21.21.61.42.1 
Dividend payout %-14.420.813.521.70 
Avg Mkt Cap Rs m13,63011,05916,62415,3918,067 
No. of employees `0004.03.7NA4.52.8 
Total wages/salary Rs m1,4091,7751,7371,7642,527 
Avg. sales/employee Rs Th3,210.03,630.9NM4,205.66,956.1 
Avg. wages/employee Rs Th348.7479.8NM396.0902.5 
Avg. net profit/employee Rs Th-121.3916.9NM218.8-1,993.0 
ORCHID PHARMA LTD INCOME DATA
Net Sales Rs m12,96913,43517,81818,73619,477 
Other income Rs m86186447562407 
Total revenues Rs m13,82913,52018,26519,29819,884 
Gross profit Rs m1,706-1,5693,5643,5661,103 
Depreciation Rs m1,3401,5491,3351,5372,519 
Interest Rs m1,5652,4231,1681,7985,227 
Profit before tax Rs m-338-5,4551,509793-6,236 
Minority Interest Rs m000020 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m010,153207-39511 
Tax Rs m1521,306154-220-125 
Profit after tax Rs m-4903,3931,562975-5,580 
Gross profit margin %13.2-11.720.019.05.7 
Effective tax rate %-44.9-23.910.2-27.82.0 
Net profit margin %-3.825.38.85.2-28.7 
ORCHID PHARMA LTD BALANCE SHEET DATA
Current assets Rs m15,95417,00515,26312,53311,014 
Current liabilities Rs m8,55810,85219,89415,51132,060 
Net working cap to sales %57.045.8-26.0-15.9-108.1 
Current ratio x1.91.60.80.80.3 
Inventory Days Days21611512713095 
Debtors Days Days1892001052234 
Net fixed assets Rs m25,54220,72220,74124,26129,440 
Share capital Rs m704704704704705 
"Free" reserves Rs m5,4798,4548,1069,3102,043 
Net worth Rs m6,3389,37710,69211,3233,800 
Long term debt Rs m26,15915,3036,04110,7429,018 
Total assets Rs m43,91639,90639,10239,38146,510 
Interest coverage x0.8-1.32.31.4-0.2 
Debt to equity ratio x4.11.60.60.92.4 
Sales to assets ratio x0.30.30.50.50.4 
Return on assets %2.414.67.07.0-0.8 
Return on equity %-7.736.214.68.6-146.9 
Return on capital %3.828.917.211.6-3.7 
Exports to sales %71.972.740.745.237.9 
Imports to sales %32.728.232.437.822.6 
Exports (fob) Rs m9,3209,7627,2598,4677,378 
Imports (cif) Rs m4,2343,7875,7737,0894,406 
Fx inflow Rs m9,59210,0527,8688,9287,513 
Fx outflow Rs m5,0065,2676,6588,2195,649 
Net fx Rs m4,5864,7851,2107091,865 
ORCHID PHARMA LTD CASH FLOW
From Operations Rs m 459 -343 3,321 7,370 1,682 
From Investments Rs m -4,770 14,128 -3,674 -2,931 -9,860 
From Financial Activity Rs m 4,311 -10,768 -778 -4,802 6,644 
Net Cashflow Rs m 0 3,016 -1,130 -362 -1,535 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 32.3%
Foreign collaborators 0.0%
Indian inst/Mut Fund 4.6%
FIIs 3.3%
ADR/GDR 4.6%
Free float 55.3%
Shareholders 84,811
Pledged promoter(s) holding 54.9%
 

Company Information

REGD OFF Orchid Towers, 313, Valluvar Kottam Road, Nungambakkam, Chennai-34
E-MAIL corporate@orchidpharma.com WEB www.orchidpharma.com
TELEPHONE (044) 2821 1000 FAX (044) 2827 5960
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Integrated Enterp., II Flr., Kences Tower, North Usman Rd., Chennai-17
AUDITOR SNB Associates
CHM: K. Raghavendra Rao (MD) COMP SEC: L. Chandrasekar YEAR OF INC: 1992 BSE CODE: 524372 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   PANACEA BIOTECH  LUPIN LTD  ELDER PHARMA  SANOFI INDIA  IPCA LABS  

Compare ORCHID PHARMA LTD With:   PANACEA BIOTECH  LUPIN LTD  ELDER PHARMA  SANOFI INDIA  IPCA LABS  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Nifty Hovers Near 10,000 Mark; Energy Stocks Witness Buying(01:30 pm)

After opening the day marginally higher, stock markets in India have continued their momentum. Presently, they are trading near their all-time high levels.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Post Demonetisation Real Estate Sales Have Collapsed, But Prices Haven't(Vivek Kaul's Diary)

Jul 11, 2017

While sales have fallen dramatically, net net home prices continue to hold on.

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The New Pharma Rally Starts NOW(Daily Profit Hunter)

Jul 12, 2017

The most hated sector is offering the best trading opportunity. Are you ready?

All You Need To Know To e-File Your Income Tax Returns(Outside View)

Jul 12, 2017

The Income Tax return filing deadline is drawing near; if you have not already filed your taxes, here's how to do it.

The Impact of GST On Banking transactions, Insurance, and Investments(Outside View)

Jul 11, 2017

PersonalFN explains how GST impacts your insurance premiums, investments, and banking transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS